Brain cancer trial aims to sharpen radiation with PET scans

NCT ID NCT05653635

Recruiting now Knowledge-focused Sponsor: Centre Paul Strauss Source: ClinicalTrials.gov ↗

First seen Feb 04, 2026 · Last updated Jun 11, 2026 · Updated 18 times

Summary

This study is for adults whose glioblastoma (a type of brain cancer) has come back after initial treatment. Researchers want to see if using a special PET scan (FDOPA-PET) to guide a precise form of radiation therapy can delay the cancer's return. About 54 participants will be randomly assigned to receive standard radiation or the PET-guided approach, and the team will track how long it takes for the tumor to grow back.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

CHRU de Nancy
NOT_YET_RECRUITING

Nancy, De, 5400, France

Contact Email: •••••@•••••

Contact
Centre Paul Strauss
RECRUITING

Strasbourg, 67033, France

Contact

Contact Email: •••••@•••••

Contact

Conditions

Explore the condition pages connected to this study.

GLIOBLASTOMA GLIOBLASTOMA